SHARE

Creative Edge Nutrition Inc (OTCMKTS:FITX) a company offering nutritional supplements and operating in active lifestyles industry issued a new letter to its shareholders. The letter highlighted that many of them are well-informed that CEN Biotech, Inc. has witnessed annoying attacks in last one year. A major part of these attacks came from a Canadian newspaper, named as “the Globe and Mail”.

The problems

A “reporter” for the Globe and Mail, Grant Robertson started with a campaign of untruths and misrepresentations to hamper the reputation of the firm. The measures were clearly directed to destroy the Company that Creative Edge’s shareholders and management have worked hard to create. Robertson has made a number of false accusations against the company and the firm’s reputed President Bill Chaaban. He said that the company is a part of insider trading as well as a “pump and dump” plan.

The shares sales

Creative Edge further added that the irresponsible accusations are made without any base and just intended to hamper the company and its strong value of shareholders holdings. Robertson alleged CEN Biotech management team of liquidating massive shares before the license application rejection news was released on March 11, 2015.

The work

Creative Edge Nutrition Inc (OTCMKTS:FITX) stated that the reported should have done the research work before making any claims. There are numerous websites that reporter should have accessed to decide whether Creative Edge management sold shares or not. In case he had done the work, he would have realized that no affiliate had submitted any 144 paperwork. Without any research the reporter made the claims as he didn’t bothered to know the facts. In fact he didn’t have a slight interest to verify the authenticity of allegations. Also, the company stated that the Health Canada rejected the license application due to unknown reasons. In last trading session, FITX shares declined more than 7% to close at $0.00660.

LEAVE A REPLY